Export 165 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is K  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
N. Kasahata, Sato, T., Onishi, I., Kitagawa, M., Uchihara, T., and Hirokawa, K., Three-Repeat Tau with Grain-Like Structures and Distribution in an 83-Year-Old Man., J Alzheimers Dis, vol. 58, no. 3, pp. 681-685, 2017.
Á. Kasza, Hunya, Á., Frank, Z., Fülöp, F., Török, Z., Balogh, G., Sántha, M., Bálind, Á., Bernáth, S., Blundell, K. L. I. M., Prodromou, C., Horváth, I., Zeiler, H. - J., Hooper, P. L., Vigh, L., and Penke, B., Dihydropyridine Derivatives Modulate Heat Shock Responses and have a Neuroprotective Effect in a Transgenic Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 53, no. 2, pp. 557-71, 2016.
K. Katisko, Kokkonen, N., Krüger, J., Hartikainen, P., Koivisto, A. M., Helisalmi, S., Korhonen, V. E., Kokki, M., Tuusa, J., Herukka, S. - K., Solje, E., Haapasalo, A., Tasanen, K., and Remes, A. M., The Association Between Frontotemporal Lobar Degeneration and Bullous Pemphigoid., J Alzheimers Dis, vol. 66, no. 2, pp. 743-750, 2018.
K. Katisko, Krüger, J., Soppela, H., Hartikainen, P., Haapasalo, A., Remes, A. M., and Solje, E., Psychopharmacological Medication Use in Frontotemporal Dementia at the Time of Diagnosis: Comparison with Alzheimer's Disease., J Alzheimers Dis, vol. 95, no. 2, pp. 677-685, 2023.
K. Katisko, Haapasalo, A., Koivisto, A., Krüger, J., Hartikainen, P., Korhonen, V., Helisalmi, S., Herukka, S. - K., Remes, A. M., and Solje, E., Low Prevalence of Cancer in Patients with Frontotemporal Lobar Degeneration., J Alzheimers Dis, vol. 62, no. 2, pp. 789-794, 2018.
M. J. Katz, Wang, C., Derby, C. A., Lipton, R. B., Zimmerman, M. E., Sliwinski, M. J., and Rabin, L. A., Subjective Cognitive Decline Prediction of Mortality: Results from the Einstein Aging Study., J Alzheimers Dis, vol. 66, no. 1, pp. 239-248, 2018.
H. Kaur, Golovko, S., Golovko, M. Y., Singh, S., Darland, D. C., and Combs, C. K., Effects of Probiotic Supplementation on Short Chain Fatty Acids in the AppNL-G-F Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 76, no. 3, pp. 1083-1102, 2020.
S. Bagewadi Kawalia, Raschka, T., Naz, M., Simoes, Rde Matos, Senger, P., and Hofmann-Apitius, M., Analytical Strategy to Prioritize Alzheimer's Disease Candidate Genes in Gene Regulatory Networks Using Public Expression Data., J Alzheimers Dis, vol. 59, no. 4, pp. 1237-1254, 2017.
K. Kawamura, Miyajima, M., Nakajima, M., Kanai, M., Motoi, Y., Nojiri, S., Akiba, C., Ogino, I., Xu, H., Kamohara, C., Yamada, S., Karagiozov, K., Ikeuchi, T., Kondo, A., and Arai, H., Cerebrospinal Fluid Amyloid-β Oligomer Levels in Patients with Idiopathic Normal Pressure Hydrocephalus., J Alzheimers Dis, vol. 83, no. 1, pp. 179-190, 2021.
S. Kawanishi, Takata, K., Itezono, S., Nagayama, H., Konoya, S., Chisaki, Y., Toda, Y., Nakata, S., Yano, Y., Kitamura, Y., and Ashihara, E., Bone-Marrow-Derived Microglia-Like Cells Ameliorate Brain Amyloid Pathology and Cognitive Impairment in a Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 64, no. 2, pp. 563-585, 2018.
T. Kawarabayashi, Nakamura, T., Sato, K., Seino, Y., Ichii, S., Nakahata, N., Takatama, M., Westaway, D., St George-Hyslop, P., and Shoji, M., Lipid Rafts Act as a Common Platform for Amyloid-β Oligomer-Induced Alzheimer's Disease Pathology., J Alzheimers Dis, vol. 87, no. 3, pp. 1189-1203, 2022.
H. Kazui, Takahashi, R., Yamamoto, Y., Yoshiyama, K., Kanemoto, H., Suzuki, Y., Sato, S., Azuma, S., Suehiro, T., Shimosegawa, E., Ishii, K., and Tanaka, T., Neural Basis of Apathy in Patients with Amnestic Mild Cognitive Impairment., J Alzheimers Dis, vol. 55, no. 4, pp. 1403-1416, 2017.
J. Thomas- Ric Keeney, Ibrahimi, S., and Zhao, L., Human ApoE Isoforms Differentially Modulate Glucose and Amyloid Metabolic Pathways in Female Brain: Evidence of the Mechanism of Neuroprotection by ApoE2 and Implications for Alzheimer's Disease Prevention and Early Intervention., J Alzheimers Dis, vol. 48, no. 2, pp. 411-24, 2015.
P. Gavin Kehoe, The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment?, J Alzheimers Dis, vol. 62, no. 3, pp. 1443-1466, 2018.
P. Gavin Kehoe, Hibbs, E., Palmer, L. E., and J Miners, S., Angiotensin-III is Increased in Alzheimer's Disease in Association with Amyloid-β and Tau Pathology., J Alzheimers Dis, vol. 58, no. 1, pp. 203-214, 2017.
P. G. Kehoe, Blair, P. S., Howden, B., Thomas, D. L., Malone, I. B., Horwood, J., Clement, C., Selman, L. E., Baber, H., Lane, A., Coulthard, E., Passmore, A. Peter, Fox, N. C., Wilkinson, I. B., and Ben-Shlomo, Y., The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) Trial., J Alzheimers Dis, vol. 61, no. 2, pp. 803-814, 2018.
A. Keleman, Wisch, J. K., Bollinger, R. M., Grant, E. A., Benzinger, T. L., Morris, J. C., Ances, B. M., and Stark, S. L., Falls Associate with Neurodegenerative Changes in ATN Framework of Alzheimer's Disease., J Alzheimers Dis, vol. 77, no. 2, pp. 843-853, 2020.
D. Kelly, Coen, R. F., Akuffo, K. Owusu, Beatty, S., Dennison, J., Moran, R., Stack, J., Howard, A. N., Mulcahy, R., and Nolan, J. M., Cognitive Function and Its Relationship with Macular Pigment Optical Density and Serum Concentrations of its Constituent Carotenoids., J Alzheimers Dis, vol. 48, no. 1, pp. 261-77, 2015.
N. Kemppainen, Joutsa, J., Johansson, J., Scheinin, N. M., Någren, K., Rokka, J., Parkkola, R., and Rinne, J. O., Long-Term Interrelationship between Brain Metabolism and Amyloid Deposition in Mild Cognitive Impairment., J Alzheimers Dis, vol. 48, no. 1, pp. 123-33, 2015.
D. Kempuraj, Selvakumar, G. Pushpavath, Thangavel, R., Ahmed, M. Ejaz, Zaheer, S., Kumar, K. Kuppamma, Yelam, A., Kaur, H., Dubova, I., Raikwar, S. P., Iyer, S. S., and Zaheer, A., Glia Maturation Factor and Mast Cell-Dependent Expression of Inflammatory Mediators and Proteinase Activated Receptor-2 in Neuroinflammation., J Alzheimers Dis, vol. 66, no. 3, pp. 1117-1129, 2018.
G. Kennedy, Hardman, R. J., Macpherson, H., Scholey, A. B., and Pipingas, A., How Does Exercise Reduce the Rate of Age-Associated Cognitive Decline? A Review of Potential Mechanisms., J Alzheimers Dis, vol. 55, no. 1, pp. 1-18, 2017.
G. Kennedy, Meyer, D., Hardman, R. J., Macpherson, H., Scholey, A. B., and Pipingas, A., Physical Fitness and Aortic Stiffness Explain the Reduced Cognitive Performance Associated with Increasing Age in Older People., J Alzheimers Dis, vol. 63, no. 4, pp. 1307-1316, 2018.
R. E. Kennedy, Cutter, G. R., Wang, G., and Schneider, L. S., Post Hoc Analyses of ApoE Genotype-Defined Subgroups in Clinical Trials., J Alzheimers Dis, vol. 50, no. 4, pp. 1205-15, 2016.
B. A. Kent, Strittmatter, S. M., and Nygaard, H. B., Sleep and EEG Power Spectral Analysis in Three Transgenic Mouse Models of Alzheimer's Disease: APP/PS1, 3xTgAD, and Tg2576., J Alzheimers Dis, vol. 64, no. 4, pp. 1325-1336, 2018.
K. P. Kepp, Sensi, S. L., Johnsen, K. B., Barrio, J. R., Høilund-Carlsen, P. F., Neve, R. L., Alavi, A., Herrup, K., Perry, G., Robakis, N. K., Vissel, B., and Espay, A. J., The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes., J Alzheimers Dis, vol. 94, no. 2, pp. 497-507, 2023.